Preparation and characterization of albendazole β-cyclodextrin complexes

Drug Development and Industrial Pharmacy

Volumn 25, Issue 12, 1999, Pages 1241-1248

  Castillo, J A ^a   Palomo Canales, J ^a   Garcia, J J ^b   Lastres, J L ^a   Bolas, F ^b   Torrado, J J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Albendazole; Bioavailability; Cyclodextrin; Solubility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; BETA CYCLODEXTRIN; MEBENDAZOLE;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; FREEZE DRYING; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRECIPITATION; STOICHIOMETRY;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOLOGICAL AVAILABILITY; CALORIMETRY, DIFFERENTIAL SCANNING; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DRUG STABILITY; FREEZE DRYING; MICE; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0032806298     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-100102294     Document Type: Article

References (20)

1. C. Villaverde, A. I. Alvarez, J. L. del Estal, and J. G. Prieto, Dev. Pharmacol. Ther., 19, 27 (1992).
2. S. Torrado, S. Torrado, J. J. Torrado, and R. Cadórniga, Int. J. Pharm., 140, 247 (1996).
3. S. Torrado, S. Torrado, R. Cadórniga, and J. J. Torrado, Int. J. Pharm., 140, 45 (1996).
4. T. Higuchi and K. A. Connors, Adv. Anal. Chem. Instrum., 4, 117 (1965).
5. M. L. López-Garcia, S. Torrado, S. Torrado, A. R. Martinez, and F. Bolas, Vet. Parasitol., 75, 209 (1998).
6. M. Rowland and T. N. Tozer, Clinical Pharmacokinetics. Concepts and Applications, Lea and Febiger, Philadelphia, 1989, pp. 459-463.
7. J. L. Blanco, J. Vila-Jato, F. Otero, and S. Anguiano, Drug Dev. Ind. Pharm., 17, 943 (1991).
8. T. Loftsson and M. E. Brewster, Pharm. Technol. Eur., 9, 26 (1997).
9. K. H. Fromming and J. Szejtli, Cydodextrins in Pharmacy, Kluwer Academic, Dordrecht, The Netherlands, 1994, p. 49.
10. T. Loftsson and M. E. Brewster, J. Pharm. Sci., 85, 1017 (1996).
11. J. Zhu, Y. Yang, and S. A. Botha, Pharm. Res., 12, S-199 (1995).
12. S. Ismail, STP Pharma Sci., 1, 321 (1991).
13. S. Ismail, STP Pharma Sci., 2, 181 (1992).
14. M. Fernández, M. V. Margarit, I. C. Rodríguez, and M. Cerezo, Int. J. Pharm., 98, 29 (1993).
15. M. Sugimoto, T. Okagaki, S. Narisawa, Y. Koida, and K. Nakajima, Int. J. Pharm., 160, 11 (1998).
16. G. F. Palmieri, D. Galli-Angeli, G. Giovannucci, and S. Martelli, Drug Dev. Ind. Pharm., 23, 27 (1997).
17. M. Pedersen, S. Bjerregaard, J. Jacobsen, A. R. Laarsen, and A. M. Sorensen, Int. J. Pharm., 165, 57 (1998).
18. M. Pedersen, Drug Dev. Ind. Pharm., 23, 331 (1997).
19. S. Torrado, M. L. López, G. Torrado, F. Bolas, S. Torrado, and R. Cadórniga, Int. J. Pharm., 156, 181 (1997).
20. B. Evrard, P. Chiap, G. Piel, T. Van Hees, F. Ghalmi, B. Losson, and L. Delattre, abstract 3-P-8, Ninth International Symposium on Cydodextrins, Santiago de Compostela, May 31-June 3, 1998.